Skip to main content
X

xAID

This company provides AI screening solutions for emergency and opportunistic pathologies in CT scans to enhance radiology workflow efficiency. Their platform automates routine findings and measurements, delivering structured reports to reduce radiologist workload and improve case prioritization. The service operates on a transparent, results-based pricing model where fees are only charged upon confirmed pathology detection.

Founded 202418700+ followers
Updated 4 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

Emergency departments face increasing demand for CT scans, while the number of radiologists struggles to keep pace, leading to delays in diagnosis and potential oversights. This shortage can result in increased workloads for radiologists, longer patient wait times, and a higher risk of missed critical findings.

Solution

xAID offers an AI-powered platform designed to automate the screening and reporting of emergency pathologies detected in CT scans. The platform prioritizes critical cases, enabling radiologists to focus on the most urgent patients first. By providing automated reports and opportunistic screening for additional findings, xAID aims to enhance workflow efficiency, reduce the time to critical intervention, and improve patient outcomes in emergency medical settings. The cloud-based platform integrates directly into existing DICOM viewers, providing radiologists with AI-driven insights without requiring additional hardware.

Target Audience

The primary target audience includes radiologists working in emergency departments, hospitals seeking to optimize their radiology workflows, and clinical researchers analyzing CT scans.

Features

  • AI-driven detection of key emergency pathologies in chest, abdomen, and pelvis CT scans.
  • Automated reporting of images, providing structured reports when radiologists are unavailable.
  • Worklist prioritization, triaging the most severe cases to ensure timely attention.
  • Opportunistic screening for non-acute findings, enabling early detection of other potential health issues.
  • Cloud-based platform accessible through standard DICOM viewers, requiring no additional hardware.
  • Research framework available for free use of the platform for scientific purposes.
  • Anonymization of data to protect patient privacy and comply with data protection regulations.
This profile is AI-generated and may contain inaccuracies.